The global non-injectable insulin market is estimated to be worth USD 1.7 billion in 2024. From 2024 to 2034, the market is projected to grow at a solid clip, registering a CAGR of 13.5%.
| Attributes | Key Insights |
|---|---|
| Global Non-injectable Insulin Market Size (2024E) | USD 1.7 billion |
| Market Value (2034F) | USD 6.1 billion |
| Value-based CAGR (2024 to 2034) | 13.5% |
Growing prevalence of diabetes worldwide is surging the demand for non-injectable insulin as patients seek more comfort and convenience from the treatment. Cultural considerations and healthcare providers' willingness to try new treatments are set to impact patient preferences and adoption of non-injectable insulin.
In the pharmaceutical industry, the non-injectable insulin market provides easy and less challenging alternatives to traditional insulin injections, such as transdermal patches, oral insulin, and inhalable insulin. The market is growing due to innovative developments in drug delivery technology, which have resulted in more dependable and effective non-injectable insulin replacements.
Technological innovations in non-injectable insulin delivery devices are estimated to improve consumer experience and adherence, resulting in revenue growth and placing firms as competitive leaders. By 2034, the market is anticipated to reach USD 6.1 billion.
From 2019 to 2023, the market has prolonged due to patient preferences for non-injectable products, fueled by advantages such as convenience, simplicity of administration, and less discomfort. The market grew at a CAGR of 17.0% between 2019 and 2023.
The advent of inhalable insulin was one of the prevalent changes in the non-injectable insulin industry. Exubera, the first inhalable insulin medication, received the United States Food & Drug Administration (FDA) approval in 2006. Afrezza's release, despite initial disappointment due to poor demand and concerns about its bulky inhaler, renewed interest in inhalable insulin, enhancing consumer acceptability.
The FDA's regulatory control, in particular, has had a key impact on the market. For non-injectable insulin solutions, strict regulatory criteria for safety, effectiveness, and quality standards have impacted clinical trial designs, product development, and market access. Although Afrezza is still the only FDA-approved inhaled insulin medication in the United States, several manufacturers have looked into creating comparable goods.
The demand for insulin is competitive. It is projected to spur innovation, enhance product offerings, and increase diabetes patients' treatment alternatives. By 2034, the market is set to surge at a CAGR of 13.5%, which is comparatively low from 2019 to 2023.
Insulin that is not injectable is now delivered more effectively because of developments in inhalation technology, including creating more accurate and effective inhaler devices. Sustained drug delivery methods, formulation optimization, and device design innovations are projected to boost market growth and enhance patient outcomes for non-injectable insulin treatment.
Leading companies are researching oral insulin formulations that can withstand digestive system conditions. They are potentially revolutionizing diabetes management by offering a comfortable, painless alternative to needles. Diabetes patients seek non-injectable insulin replacements due to needle phobia and daily hassles, pushing pharmaceutical companies to invest in unique products.
Regulatory bodies such as the FDA are evaluating and approving new insulin products, leading to a booming market. Pharmaceutical companies are collaborating with healthcare providers, IT companies, and research organizations to propel the development of insulin-delivery products.
Leading healthcare companies and professionals prioritize cost and accessibility to ensure all patients can access enhanced non-injectable solutions, fueling the market. The design process for insulin delivery systems is vital for diabetes patients, considering their preferences and input, thereby accelerating demand for non-injectable insulin.
The table below shows the estimated growth rates of the leading five nations. South Korea, Japan, and the United Kingdom are set to emerge as profitable markets for companies, recording CAGRs of 16.0%, 15.2%, and 14.6%, respectively, through 2034.
| Countries | Projected CAGR (2024 to 2034) |
|---|---|
| United States | 13.8% |
| United Kingdom | 14.6% |
| China | 14.2% |
| South Korea | 16.0% |
| Japan | 15.2% |
The table below highlights key countries’ market revenues. The United States and China are forecast to remain the leading consumers of non-injectable insulin, with predicted valuations of USD 1.1 billion and USD 1.0 billion, respectively, in 2034.
| Countries | Market Value (2034) |
|---|---|
| United States | USD 1.1 billion |
| United Kingdom | USD 243.2 million |
| China | USD 1.0 billion |
| South Korea | USD 395.6 million |
| Japan | USD 665.7 million |
Japan's non-injectable insulin market is projected to reach a valuation of around USD 665.7 million by 2034. Japan, with its high diabetes prevalence, urbanization, and growing healthcare infrastructure, is experiencing increased demand for innovative diabetes management solutions.
The growing awareness of insulin's convenience and reduced pain are projected to fuel the adoption of non-injectable insulin in Japan. Government initiatives and collaborations with pharmaceutical companies further promote market growth, positioning Japan as a leading player in the market.
The competitive landscape in Japan's pharmaceutical industry is projected to spur innovation and sales expansion in the non-injectable insulin market. Leading companies in Japan invest in research & development to enhance product formulas, delivery methods, and patient care services to set themselves apart.
Demand for non-injectable insulin is increasing in the United States, with a projected CAGR of 13.8% through 2034. MannKind Corporation's Afrezza is the primary insulin product for adults with diabetes, developed in the United States. It is a rapid-acting inhaled insulin available in powder form and regulated through an inhaler device.
Patient adoption and acceptability of non-injectable insulin treatments is determined by a number of factors, including cost, affordability, availability, efficacy, and safety. Campaigns for patient & healthcare professional education and awareness are planned to promote the benefits and increase adoption of non-injectable insulin therapy in the United States.
The non-injectable insulin market is projected to increase in South Korea at a CAGR of 16.0% through 2034. South Korea is anticipated to undergo research & development activities to improve pharmaceutical compositions, delivery systems, and patient outcomes, fueling demand for non-injectable insulin. Collaborations among pharmaceutical firms, healthcare providers, and regulatory bodies are vital for pouring innovation and increasing access to non-injectable insulin therapy in South Korea.
Pills stand atop the pile in the product type segment. The segment is anticipated to grow at a CAGR of 13.3% by 2034. Drug stores remain the predominant mode of distribution channel.
| Segment | Value CAGR (2024 to 2034) |
|---|---|
| Pills (Product) | 13.3% |
| Drug Stores (Distribution Channel) | 13.1% |
Oral insulin tablets are projected to rise at 13.3% CAGR through 2034. The marketing and distribution of insulin pills is dependent on permission from health authorities such as the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA). Oral medicines are projected to improve insulin therapy adherence in individuals who find injections uncomfortable or unpleasant.
In January 2023, for instance, researchers at the UiT Norway's Arctic University published a paper in Nature Nanotechnology. It states that out of the 425 million people suffering from diabetes across the globe, nearly 75 million inject themselves with insulin. However, this can soon change as researchers have found a novel method to supply smart insulin. It can be taken by the patient as a capsule or with any other food item, including chocolates.
Drug stores provide non-injectable medicines and specialized healthcare services, whereas specialty pharmacies focus on complicated medical conditions such as diabetes. Drug stores offer prescription counseling, adherence monitoring, and insurance help, making them important to ensure easy and convenient pharmaceutical access.
A few leading companies and manufacturers dominate the market. They are launching new products worldwide to meet consumer demands and investing in research & development. Key companies also use several growth strategies to inflate their market reach and customer base, including mergers, acquisitions, partnerships, and collaborations.
For instance
Table 1: Global Market Value (US$ million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 4: Global Market Volume (Units) Forecast by Product, 2019 to 2034
Table 5: Global Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 6: Global Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 7: North America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 8: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 9: North America Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 11: North America Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 13: Latin America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 14: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 15: Latin America Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 16: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034
Table 17: Latin America Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 19: Western Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 20: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 21: Western Europe Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 22: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 23: Western Europe Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 24: Western Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 25: Eastern Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 26: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Eastern Europe Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 28: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034
Table 29: Eastern Europe Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 30: Eastern Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 31: South Asia and Pacific Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 32: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 33: South Asia and Pacific Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 34: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034
Table 35: South Asia and Pacific Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 36: South Asia and Pacific Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 37: East Asia Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 38: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 39: East Asia Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 40: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034
Table 41: East Asia Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 42: East Asia Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 43: Middle East and Africa Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 44: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 45: Middle East and Africa Market Value (US$ million) Forecast by Product, 2019 to 2034
Table 46: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034
Table 47: Middle East and Africa Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034
Table 48: Middle East and Africa Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Figure 1: Global Market Value (US$ million) by Product, 2024 to 2034
Figure 2: Global Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 3: Global Market Value (US$ million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 9: Global Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 12: Global Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 13: Global Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 14: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 15: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 16: Global Market Attractiveness by Product, 2024 to 2034
Figure 17: Global Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 18: Global Market Attractiveness by Region, 2024 to 2034
Figure 19: North America Market Value (US$ million) by Product, 2024 to 2034
Figure 20: North America Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 21: North America Market Value (US$ million) by Country, 2024 to 2034
Figure 22: North America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 23: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 26: North America Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 27: North America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 28: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 29: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 30: North America Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 31: North America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 34: North America Market Attractiveness by Product, 2024 to 2034
Figure 35: North America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 36: North America Market Attractiveness by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ million) by Product, 2024 to 2034
Figure 38: Latin America Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 39: Latin America Market Value (US$ million) by Country, 2024 to 2034
Figure 40: Latin America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 41: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 44: Latin America Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 45: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 48: Latin America Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 49: Latin America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 50: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 52: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 53: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 55: Western Europe Market Value (US$ million) by Product, 2024 to 2034
Figure 56: Western Europe Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 57: Western Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 58: Western Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 59: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 62: Western Europe Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 63: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 66: Western Europe Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 67: Western Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 68: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 70: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 71: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 72: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 73: Eastern Europe Market Value (US$ million) by Product, 2024 to 2034
Figure 74: Eastern Europe Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 75: Eastern Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 76: Eastern Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 77: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 80: Eastern Europe Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 81: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 85: Eastern Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 88: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 89: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 90: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 91: South Asia and Pacific Market Value (US$ million) by Product, 2024 to 2034
Figure 92: South Asia and Pacific Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 93: South Asia and Pacific Market Value (US$ million) by Country, 2024 to 2034
Figure 94: South Asia and Pacific Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 95: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 98: South Asia and Pacific Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 99: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 103: South Asia and Pacific Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 106: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 107: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 109: East Asia Market Value (US$ million) by Product, 2024 to 2034
Figure 110: East Asia Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 111: East Asia Market Value (US$ million) by Country, 2024 to 2034
Figure 112: East Asia Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 113: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 116: East Asia Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 117: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 118: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 120: East Asia Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 121: East Asia Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 122: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 123: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 124: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 125: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 126: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 127: Middle East and Africa Market Value (US$ million) by Product, 2024 to 2034
Figure 128: Middle East and Africa Market Value (US$ million) by Distribution Channel, 2024 to 2034
Figure 129: Middle East and Africa Market Value (US$ million) by Country, 2024 to 2034
Figure 130: Middle East and Africa Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 131: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 134: Middle East and Africa Market Value (US$ million) Analysis by Product, 2019 to 2034
Figure 135: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034
Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 138: Middle East and Africa Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034
Figure 139: Middle East and Africa Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 142: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 143: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The industry is set to reach a valuation of USD 1.7 billion in 2024.
Demand for non-injectable insulin is set to rise at 13.5% CAGR by 2034.
The industry is projected to reach USD 6.1 billion in 2034.
Novo Nordisk, Sanofi, and Eli Lilly are the key players.
The pills segment is estimated to hold a significant market share in 2024.
Explore Similar Insights
Non-injectable Insulin Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
